CANCER CHEMOPREVENTION: A New Way to Treat Cancer Before It Happens

[1]  E. Constant,et al.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. , 1998 .

[2]  C. Rock,et al.  Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. , 1997, Journal of the National Cancer Institute.

[3]  R. S. Rogers,et al.  Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). , 1997, Journal of medicinal chemistry.

[4]  V. Steele,et al.  Progress in clinical chemoprevention. , 1997, Seminars in oncology.

[5]  Bruce W. Turnbull,et al.  Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .

[6]  G. Omenn,et al.  Clinical development plans for cancer chemopreventive agents , 1996 .

[7]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[8]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[9]  M. Ruffin,et al.  Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring. , 1996, Archives of family medicine.

[10]  B. Rigas,et al.  Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. , 1996, Experimental cell research.

[11]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[12]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[13]  C. L. Bird,et al.  Red cell and plasma folate, folate consumption, and the risk of colorectal adenomatous polyps. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  W C Willett,et al.  Aspirin and the risk of colorectal cancer in women. , 1995, The New England journal of medicine.

[15]  D. Alberts,et al.  Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. , 1995, Cancer research.

[16]  J. Potter.  Risk factors for colon neoplasia--epidemiology and biology. , 1995, European journal of cancer.

[17]  B. Rigas,et al.  Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. , 1995, The Journal of clinical investigation.

[18]  S Jothy,et al.  Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. , 1995, Cancer research.

[19]  R. Palumbo,et al.  Effectiveness of β-carotene in cancer chemoprevention , 1995 .

[20]  J S Lee,et al.  Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. , 1995, The New England journal of medicine.

[21]  M. Dawson,et al.  Evidence for the Involvement of Retinoic Acid Receptor RAR-dependent Signaling Pathway in the Induction of Tissue Transglutaminase and Apoptosis by Retinoids (*) , 1995, The Journal of Biological Chemistry.

[22]  C. Rao,et al.  Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. , 1995, Cancer research.

[23]  C. la Vecchia,et al.  Selected micronutrient intake and the risk of colorectal cancer. , 1994, British Journal of Cancer.

[24]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[25]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[26]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[27]  W. Peters,et al.  Quantification of induction of rat oesophageal, gastric and pancreatic glutathione and glutathione S-transferases by dietary anticarcinogens. , 1994, Carcinogenesis.

[28]  J. Gutteridge.  Antioxidants, nutritional supplements and life-threatening diseases. , 1994, British journal of biomedical science.

[29]  E. Rimm,et al.  Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals , 1994, Annals of Internal Medicine.

[30]  L. Marchand,et al.  Effects of micronutrients and antioxidants on lipid peroxidation in human plasma and in cell culture. , 1994, Cancer letters.

[31]  D. Alberts,et al.  Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. , 1994, Journal of the National Cancer Institute.

[32]  G. Omenn,et al.  The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. , 1994, Cancer research.

[33]  R. Everson,et al.  Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.

[34]  S. H. Brown,et al.  Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. , 1994, Archives of internal medicine.

[35]  S. Lippman,et al.  Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. , 1994, Journal of the National Cancer Institute.

[36]  Bert Vogelstein,et al.  Hypermutability and mismatch repair deficiency in RER+ tumor cells , 1993, Cell.

[37]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[38]  M. Gail,et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.

[39]  G. Kelloff,et al.  Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. , 1993, Carcinogenesis.

[40]  J D Hardcastle,et al.  Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. , 1993, BMJ.

[41]  S Wacholder,et al.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. , 1993, Journal of the National Cancer Institute.

[42]  J. Baron,et al.  Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. , 1993, Journal of the National Cancer Institute.

[43]  E. Rimm,et al.  Folate, methionine, and alcohol intake and risk of colorectal adenoma. , 1993, Journal of the National Cancer Institute.

[44]  G. Kelloff,et al.  Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. , 1993, Cancer research.

[45]  K. Calzone,et al.  Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[47]  J. Christman,et al.  Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. , 1993, Carcinogenesis.

[48]  L. Roncucci,et al.  Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas , 1993, Diseases of the colon and rectum.

[49]  W. Zheng,et al.  Serum micronutrients and the subsequent risk of oral and pharyngeal cancer. , 1993, Cancer research.

[50]  R. Weber,et al.  Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. , 1993, The New England journal of medicine.

[51]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[52]  G. Andriole,et al.  The effect of finasteride in men with benign prostatic hyperplasia. , 1992, The Journal of urology.

[53]  S. Bhide,et al.  Curcumin as an inhibitor of cancer. , 1992, Journal of the American College of Nutrition.

[54]  V. Steele,et al.  Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. , 1992, Cancer research.

[55]  R Reid,et al.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. , 1992, Obstetrics and gynecology.

[56]  G W Comstock,et al.  Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. , 1992, American journal of epidemiology.

[57]  Early Breast Cancer Trialists' Collaborative Group.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992, The Lancet.

[58]  M. Thun,et al.  Aspirin use and reduced risk of fatal colon cancer. , 1991, The New England journal of medicine.

[59]  J. Stanford,et al.  Depot‐medroxyprogesterone acetate (DMPA) and risk of edometrial cancer , 1991, International journal of cancer.

[60]  P. Vielh,et al.  Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.

[61]  L. Santamaria,et al.  Free radicals as carcinogens and their quenchers as anticarcinogens , 1991, Medical oncology and tumor pharmacotherapy.

[62]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[63]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[64]  Thomas Db,et al.  Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. , 1991, International journal of cancer.

[65]  A. Schatzkin,et al.  Antioxidant micronutrients in cancer prevention. , 1991, Hematology/oncology clinics of North America.

[66]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[67]  L J Peters,et al.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.

[68]  D. Alberts,et al.  Effects of dietary wheat bran fiber on rectal epithelial cell proliferation in patients with resection for colorectal cancers. , 1990, Journal of the National Cancer Institute.

[69]  A. Majumdar,et al.  Attenuation of azoxymethane-induced colonic mucosal ornithine decarboxylase and tyrosine kinase activity by calcium in rats. , 1989, Cancer research.

[70]  M. Yaniv,et al.  The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes , 1989, Journal of virology.

[71]  M. Lesser,et al.  Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. , 1989, Journal of the National Cancer Institute.

[72]  Y. Wax,et al.  Oral calcium suppresses increased rectal epithelial proliferation of persons at risk of colorectal cancer. , 1989, Gut.

[73]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[74]  W. R. Bruce,et al.  A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. , 1988, Cancer research.

[75]  H. Stich,et al.  Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta‐carotene and with beta‐carotene plus vitamin A , 1988, International journal of cancer.

[76]  T. R. Broker,et al.  Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies , 1988, Journal of virology.

[77]  L. Watson,et al.  Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. , 1988, Cancer research.

[78]  R. Tarone,et al.  Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. , 1988, The New England journal of medicine.

[79]  A. Pegg,et al.  Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. , 1988, Cancer research.

[80]  G. Kelloff,et al.  Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. , 1987, Cancer research.

[81]  C. Croce,et al.  Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[82]  W. Hong,et al.  13-cis-retinoic acid in the treatment of oral leukoplakia. , 1986, The New England journal of medicine.

[83]  S. Thorgeirsson,et al.  Effect of inhibitors of ornithine decarboxylase on retrovirus induced transformation of murine erythroid precursors in vitro. , 1986, Cancer research.

[84]  H. Thompson,et al.  Effect of D,L-2-difluoromethylornithine and endocrine manipulation on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. , 1986, Carcinogenesis.

[85]  L. Gissmann,et al.  The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. , 1985, The Journal of general virology.

[86]  E. Barrett-Connor,et al.  DIETARY VITAMIN D AND CALCIUM AND RISK OF COLORECTAL CANCER: A 19-YEAR PROSPECTIVE STUDY IN MEN , 1985, The Lancet.

[87]  Morris Pollard,et al.  Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats. , 1983, Journal of the National Cancer Institute.

[88]  R. Mehta,et al.  Inhibition of carcinogenesis by retinoids. , 1983, Cancer research.

[89]  G. Zon,et al.  31P NMR kinetic studies of the intra- and intermolecular alkylation chemistry of phosphoramide mustard and cognate N-phosphorylated derivatives of N,N-bis(2-chloroethyl)amine. , 1982, Journal of medicinal chemistry.

[90]  H. Bussey,et al.  A randomized trial of ascorbic acid in polyposis coli , 1982, Cancer.

[91]  N. Krinsky,et al.  Interaction of oxygen and oxy-radicals with carotenoids. , 1982, Journal of the National Cancer Institute.

[92]  M. Pollard,et al.  Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. , 1981, Science.

[93]  M. Sporn.  Approaches to prevention of epithelial cancer during the preneoplastic period. , 1976, Cancer research.

[94]  G. Pipkin,et al.  Inhibitory Effect of L-Ascorbate on Tumor Formation in Urinary Bladders Implanted with 3-Hydroxyanthranilic Acid∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[95]  M. Karagas,et al.  Risk of squamous cell carcinoma of the skin in relation to plasma selenium, alpha-tocopherol, beta-carotene, and retinol: a nested case-control study. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[96]  C. Redmond,et al.  Design and current status of the NSABP breast cancer prevention trial. , 1996, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[97]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[98]  Pemrick Sm,et al.  The retinoid receptors. , 1994 .

[99]  M. Bolla,et al.  Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study. , 1994, European journal of cancer.

[100]  H. Wiseman.  Tamoxifen: Molecular Basis of Use in Cancer Treatment and Prevention , 1994 .

[101]  H. Gerster.  Anticarcinogenic effect of common carotenoids. , 1993, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[102]  C. Boone,et al.  Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention , 1993, Journal of cellular biochemistry. Supplement.

[103]  V. Steele,et al.  Intermediate biomarkers of precancer and their application in chemoprevention , 1992, Journal of cellular biochemistry. Supplement.

[104]  G. Brandi,et al.  Effect of vitamin A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas. , 1992, Journal of the National Cancer Institute.

[105]  F. X. Bosch,et al.  HPV and cervical neoplasia: review of case-control and cohort studies. , 1992, IARC scientific publications.

[106]  M. Lipkin.  Gastrointestinal cancer: Pathogenesis, risk factors and the development of intermediate biomarkers for chemoprevention studies , 1992, Journal of cellular biochemistry. Supplement.

[107]  S. Tannenbaum,et al.  Inhibition of nitrosamine formation by ascorbic acid. , 1991, The American journal of clinical nutrition.

[108]  D. Medina,et al.  Current ideas on selenium as a chemopreventive agent. , 1988, Pathology and immunopathology research.

[109]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[110]  Morris Pollard,et al.  Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. , 1980, Cancer treatment reports.